Dr. Royal is board-certified in anesthesiology, pain medicine and internal medicine. At AcelRx, which specializes in development of pain treatments, Dr. Royal will manage late-stage and post-approval clinical direction and medical affairs. He will work with clinical trial design and management, clinical publications, regulatory interactions and more.
For the past six years, Dr. Royal has worked with Cadence Pharmaceuticals, most recently as vice president of clinical development and medical affairs. He was responsible for the completion of an acetaminophen injection clinical development program and new drug application.
More Articles on Anesthesia:
Study: Anesthesia Drug’s Amnesia Does Not Block Emotional Arousal
Kristy Floyd Joins Zotec Partners as Director of Anesthesia Business Development
Sheridan Healthcare Appoints Dr. Steven Sheinman to New Ambulatory Anesthesia Position
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
